The supramolecular processing of liposomal doxorubicin hinders its therapeutic efficacy in cells by Annalisa Carretta, Aldo Moscardini, Giovanni Signore, Doriana Debellis, Federico Catalano, Roberto Marotta, Valentina Palmieri, Giulia Tedeschi, Lorenzo Scipioni, Daniela Pozzi, Giulio Caracciolo, Fabio Beltram, Francesco Cardarelli

Subjects: Get full text

Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer by Yuanyuan Shen, Qingling Hua, Menghao Dong, Wei Jin, Xueyang Hu, Kangsheng Gu

Subjects: Get full text

The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity by Saba Dadpour, Amin Mehrabian, Mahdieh Arabsalmani, Elaheh Mirhadi, Anis Askarizadeh, Mohammad Mashreghi, Mahmoud Reza Jaafari

Subjects: Get full text